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28 Abstract
29 Introduction: Activation of the parasympathetic nervous system has been reported to have an 
30 antiarrhythmic role during ischemia-reperfusion injury by decreasing the arrhythmia triggers. 
31 Furthermore, it was reported that the parasympathetic neurotransmitter acetylcholine is able to 
32 modulate the ATP-dependent K-current (IK-ATP), a crucial current activated during hypoxia. 
33 However, the possible significance of this current modulation in the antiarrhythmic 
34 mechanism is not fully clarified. 
35 Methods: Action potentials were measured using the conventional microelectrode technique 
36 from canine left ventricular papillary muscle and free-running Purkinje fibers, under normal 
37 and hypoxic conditions. Ionic currents were measured using the whole-cell configuration of 
38 the patch clamp method.
39 Results: 5 μM acetylcholine did not influence the action potential duration (APD) either in 
40 Purkinje fibers or in papillary muscle preparations. In contrast, it significantly lengthened the 
41 APD and suppressed the Purkinje–ventricle APD dispersion when it was administered after 
42 5 μM pinacidil application. 3 μM carbachol reduced the pinacidil-activated IK-ATP under 
43 voltage-clamp condition. Acetylcholine lengthened the ventricular action potential under 
44 simulated ischemia condition.
45 Conclusion: In this study we found that acetylcholine inhibits the IK-ATP and thus suppresses 
46 the ventricle-Purkinje APD dispersion. We conclude that parasympathetic tone may reduce 
47 the arrhythmogenic substrate exerting a complex antiarrhythmic mechanism during hypoxic 
48 conditions. 
49
50 Key words: acetylcholine, Purkinje fibers, papillary muscles, hypoxia
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51 Introduction
52 The parasympathetic nervous system has a crucial role in controlling the actual heart rate and 
53 impulse propagation via influencing the sinoatrial and atrioventricular nodes (Higgins et al., 
54 1973). The parasympathetic nerve endings operate by releasing acetylcholine that acts on 
55 M2-receptors, activating several intracellular signaling routes, and ultimately influencing the 
56 cardiac ion channels (Harvey and Belevych, 2003). Even though the parasympathetic nervous 
57 system primarily innervates the supraventricular areas of the heart, there are certain important 
58 ion channels in the ventricular muscle that are known to be influenced by the release of 
59 acetylcholine. It has been previously reported that the inward rectifier potassium current (IK1; 
60 Koumi et al., 1995) and the slow component of the delayed rectifier (IKs; Pappano and 
61 Carmeliet, 1979) are inhibited, whereas IK-ATP and IK-ACh are activated by acetylcholine via 
62 G proteins (Terzic et al, 1994; Ito et al., 1994; Kim et al., 1997).
63
64 The importance of these effects of acetylcholine is underpinned by the fact that the activation 
65 of IK-ATP channels is well known during hypoxia/ischemia, in which situations the duration of 
66 the action potential is shortened (Weiss and Venkatesh, 1993). Furthermore, it was reported 
67 that vagal activation is also facilitated under ischemia–reperfusion (Recordati et al., 1971). 
68 This vagal activation during hypoxia could be antiarrhythmic, since it was reported that 
69 increased parasympathetic tone reduces the catecholaminerg-induced early and delayed 
70 afterdepolarizations (arrhythmia triggers) (Song et al., 1992), as well as the incidence of 
71 ventricular fibrillation (Zuanetti et al., 1987; Collins and Billman, 1989). However, the 
72 underlying mechanism of antiarrhythmic effect of M2-receptor activation is not fully clarified. 
73 Arrhythmias may develop when an arrhythmogenic substrate (e. g., dispersion of 
74 repolarization) and arrhythmia triggers (e.g.: early and delayed afterdepolarizations) 
75 simultaneously exist in the heart. The arrhythmogenic substrate could be prominent at 
76 Purkinje–ventricle connection because of the relatively weak electrotonic coupling due to low 
77 number of gap junctions (Varró and Baczkó, 2010). As a consequence of the different 
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78 pharmacological susceptibility of Purkinje fiber and ventricular muscle (Baláti et al, 1998), 
79 the activation of IK-ATP may modulate the Purkinje and ventricular action potential duration 
80 (APD) to different extents, and the developed APD dispersion may contribute to the onset of 
81 arrhythmias.
82
83 The objective of this study was the investigation of the possible effect of acetylcholine on the 
84 IK-ATP and on the IK-ATP-mediated action potential dispersion under normal and hypoxic 
85 conditions. 
86
87 Methods
88 Human tissues
89 Non-diseased human hearts that were unusable for transplantation (based on logistical, not 
90 patient-related considerations) were obtained from organ donors. Before cardiac explanation, 
91 organ donor patients did not receive medication except dobutamine, furosemide and plasma 
92 expanders. The investigations conform to the principles outlined in the Declaration of 
93 Helsinki of the World Medical Association. All experimental protocols were approved by the 
94 Scientific and Research Ethical Committee of the Medical Scientific Board at the Hungarian 
95 Ministry of Health (ETT-TUKEB), under ethical approval No 4991-0/2010-1018EKU 
96 (339/PI/010). Human cardiac tissue was stored in cardioplegic solution at 4°C for 4–8 hours.
97
98 Animals
99 All experiments using canine cardiac preparations were carried out in compliance with the 
100 Guide for the Care and Use of Laboratory Animals (USA NIH publication NO 85-23, revised 
101 1996) and conformed to the Directive 2010/63/EU of the European Parliament. The protocols 
102 have been approved by the Ethical Committee for the Protection of Animals in Research of 
103 the University of Szeged, Szeged, Hungary (approval number: I-74-24-2017) and by the 
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104 Department of Animal Health and Food Control of the Ministry of Agriculture and Rural 
105 Development (authority approval number XIII/3331/2017).
106
107 Conventional microelectrode technique
108 Ventricular (papillary or trabecular) muscles were obtained from the right ventricle of canine 
109 hearts. Free-running Purkinje fibers were identified as false tendons and isolated from both 
110 ventricles of human and canine hearts. Canine hearts were removed through a right lateral 
111 thoracotomy from anesthetized (thiopental 30 mg/kg i.v.) mongrel dogs of either sex 
112 weighing 10–15 kg. At impalement, Purkinje fibers were observed under a surgical 
113 microscope (Zeiss OPMI PRO). The preparations were placed in Locke’s solution and 
114 allowed to equilibrate for at least 2 hours while superfused (flow rate 4-5 ml/min) also with 
115 Locke’s solution containing (in mM): NaCl 120, KCl 4, CaCl2 2, MgCl2 1, NaHCO3 22, and 
116 glucose 11. The pH of this solution was 7.40 to 7.45 when gassed with 95% O2 and 5% CO2 
117 at 37 °C. In the experiments where the effects of tissue hypoxia were examined, we changed 
118 the gas mixture to 95% N2 and 5% CO2, pH remained at 7.40 to 7.45. All experiments were 
119 performed at 37 °C. During the equilibration period, preparations were stimulated at a basic 
120 cycle length of 500 ms. Electrical pulses of 0.5–2 ms in duration at twice the diastolic 
121 threshold in intensity (S1) were delivered to the preparations through bipolar platinum 
122 electrodes. Transmembrane potentials were recorded using glass capillary microelectrodes 
123 filled with 3 M KCl (tip resistance: 5 to 15 MΩ). The microelectrodes were coupled through 
124 an Ag-AgCl junction to the input of a high-impedance, capacitance-neutralizing amplifier 
125 (Experimetria 2011). Intracellular recordings were displayed on a storage oscilloscope 
126 (Hitachi V-555) and led to a computer system (APES) designed for on-line determination of 
127 the following parameters: resting membrane potential, action potential amplitude, action 
128 potential duration at 10% to 90% repolarization and the maximum rate of rise of the action 
129 potential upstroke (Vmax). Control recordings were obtained after equilibration period. The 
130 compounds used in all experiments were purchased from Sigma/Merck.
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131 2.3. Cell isolation
132 Ventricular myocytes were enzymatically dissociated from the left ventricle of dog hearts. 
133 Canine hearts were removed through a right lateral thoracotomy from anesthetized (thiopental 
134 30 mg/kg i.v.) mongrel dogs of either sex weighing 10–15 kg. Cardiac myocytes were isolated 
135 from the left ventricle, containing an arterial branch through which the segment was perfused 
136 on a Langendorff apparatus with solutions in the following sequence: normal Tyrode's 
137 solution (containing in mM: 144 mM NaCl, 0.4 mM NaH2PO4, 4 mM KCl, 0.53 mM MgSO4, 
138 1.8 mM CaCl2, 5.5 mM Glucose, 5 mM HEPES, pH 7.4 adjusted with NaOH) for 10 min, 
139 Ca2+-free Tyrode solution for 10 min and Ca2+-free Tyrode solution containing collagenase 
140 (Worthington type II, 0.66 mg/mL). To the final perfusion solution protease (type XIV, 0.12 
141 mg/mL) was added at the 15 and the 30 minutes for digestion.
142
143 2.4. Measurement of ionic currents
144 One drop of cell suspension was placed in a transparent recording chamber mounted on the 
145 stage of an inverted microscope (Olympus IX51, Tokyo, Japan), and individual myocytes 
146 were allowed to settle and adhere to the chamber bottom for at least 5–10 min before 
147 superfusion was initiated and maintained by gravity. Only rod-shaped cells with clear 
148 striations were used. HEPES-buffered Tyrode’s solution (composition in mM: NaCl 144, 
149 NaH2PO4 0.4, KCl 4.0, CaCl2 1.8, MgSO4 0.53, glucose 5.5 and HEPES 5.0, at pH of 7.4) 
150 was used as the normal superfusate. During the measurement of IK-ATP, 1 µM nisoldipine was 
151 added to the bath solution to block ICaL, IKr was blocked by 0.1 µM dofetilide, and IKs was 
152 blocked by 0.5 µM HMR-1556. Micropipettes were fabricated from borosilicate glass 
153 capillaries (Science Products GmbH, Hofheim, Germany), using a P-97 Flaming/Brown 
154 micropipette puller (Sutter Co, Novato, CA, USA), and had a resistance of 1.5–2.5 MΩ when 
155 filled with pipette solution. The membrane currents were recorded with Axopatch-200B 
156 amplifiers (Molecular Devices, Sunnyvale, CA, USA) by applying the whole-cell 
157 configuration of the patch-clamp technique. The membrane currents were digitized with 250 
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158 kHz analogue to digital converters (Digidata 1440A, Molecular Devices, Sunnyvale, CA, 
159 USA) under software control (pClamp 8 and pClamp 10, Molecular Devices, Sunnyvale, CA, 
160 USA).  The composition of the pipette solution (in mM) was the following: KOH 110, KCl 
161 40, K2ATP 5, MgCl2 5, EGTA 5, HEPES 10 and GTP 0.1 (pH was adjusted to 7.2 by aspartic 
162 acid). 
163
164 2.5 Statistical analysis
165 Results are expressed as mean ± S.E.M. Normality of distributions was verified using 
166 Shapiro-Wilk test, and homogeneity of variances was verified using Bartlett's test in each 
167 treatment group. Statistical comparisons were made using analysis of variance (ANOVA) for 
168 repeated measurements, followed by Bonferroni’s post-hoc test. Differences were considered 
169 significant when p < 0.05.
170
171 Results
172 1. Acetylcholine lengthened the APD after pinacidil-mediated action potential shortening
173 Canine Purkinje fibers and ventricular papillary muscles were paced at 500 ms cycle length. 
174 In canine Purkinje fibers (PFs; n=15), acetylcholine (5 µM) did not affect the repolarization 
175 (233.6±4.7 to 231.7±4.6; Figures 1A and 1E). In contrast, in canine Purkinje fibers (n=8), the 
176 IK-ATP activator pinacidil, applied in 5 μM concentration, significantly abbreviated APD90 
177 (207.7±7.0 ms vs 113.1±9.1 ms, p<0.05) values. After steady state was reached, acetylcholine 
178 was administered. Within 3 minutes, acetylcholine prolonged APD90 to 147.3±7.4 ms, 
179 partially reversing the effects of pinacidil (Figures 1B and 1E; p<0.05).
180
181 Similarly, as observed in Purkinje fibers, 5 μM acetylcholine alone failed to influence the 
182 APD of the ventricular muscle (APD90: 172.6±5.7 ms vs 172.8±5.3 ms). Pinacidil (n=5; 
183 5 μM) pretreatment significantly abbreviated the APD90 value (187.9±4.5 ms vs 
184 163.7±6.4 ms, p<0.05), similarly to the effects observed in the case of PFs. After a period of 
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185 30 minutes, sufficient to reach a steady state, acetylcholine was added to the superfusate. 
186 Within 4 minutes, acetylcholine (5 μM) prolonged APD90 to 172.1±7.4 ms (p<0.05), thus 
187 partially reversing the effects of pinacidil (Figures 1D and 1E). 
188
189 2. Acetylcholine decreased the calculated APD dispersion between PF and VM
190 The changes in the difference between the APD90 values of PF and VM can be used to infer 
191 the effects of pinacidil and acetylcholine on the dispersion between these cardiac tissue types 
192 (Figure 2). The control APD90 dispersion (9.5%, 20 ms) was significantly increased upon 
193 5 μM pinacidil application (44.7%, 51 ms). On the other hand, subsequently applied 5 μM 
194 acetylcholine markedly decreased the repolarization heterogeneity (16.9%, 28 ms; p<0.05). 
195
196 3. Carbachol decreased the pinacidil-induced current activation
197 During ionic current measurements, voltage ramps were used from a holding potential of 
198 -90 mV. Membrane potential was hyperpolarized to -120 mV, and then was slowly (over 36 s) 
199 depolarized to 60 mV. Ionic currents were analyzed and compared at 0 and +30 mV. We 
200 found that carbachol did not change the control current when it was applied without pinacidil 
201 (0 mV - control: 0.20±0.2 pA/pF vs 3 μM carbachol: 0.32±0.2 pA/pF, n=6 and +30 mV - 
202 control: 0.55±0.4 pA/pF vs 3 μM carbachol: 0.74±0.3 pA/pF, n=6). In contrast, when 5 μM 
203 pinacidil was applied first, subsequently employed carbachol significantly reduced the current 
204 at both voltages (0 mV – control: 0.24±0.2 pA/pF  5 μM pinacidil: 2.03±0.3 pA/pF  3 
205 μM carbachol: 1.51±0.4 pA/pF, n=8, p<0.05. +30 mV - control: 0.78±0.6 pA/pF  5 μM 
206 pinacidil: 3.17±0.3 pA/pF  3 μM carbachol: 2.26±0.3 pA/pF, n=8, p<0.05). 
207
208 These measurements were carried out with acetylcholine as well. However, we found 
209 carbachol to be more stable during the applied long voltage protocol. 
210
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211 4. Acetylcholine restored the APD after hypoxia-induced action potential shortening
212 Simulated hypoxia, achieved by gassing the solution with N2 and CO2 instead of O2 and CO2, 
213 resulted in a significant abbreviation of APD90 from 181.4±5.7 ms to 135.0±8.6 ms (p<0.05, 
214 Figures 4A and 4B), and a decrease in amplitude (103.7±2.8 mV vs 92±3.5 mV). The 
215 maximum rate of depolarization was also decreased (185.8±15.8 V/s vs 156.1±20.6 V/s). 
216 When applied during hypoxia, 5 μM acetylcholine caused a significant APD90 prolongation to 
217 164.4±4.4 ms, partially reversing the effect of hypoxia on the repolarization. AMP returned to 
218 a normal range (102.1±1.6 mV), while Vmax remained at 156.0±16.1 V/s.
219
220 5. Acetylcholine caused a slight abbreviation in human Purkinje fibers
221 In human PFs (n=2), acetylcholine in 5 μM concentration caused a slight abbreviation of 
222 APD90 from 269.0±28.4 to 251.6±42.85 ms and APD50 from 184.4±20.0 ms to 
223 173.3±27.1 ms without affecting other characteristics of the action potential (Figure 5).
224
225 Discussion
226 In this study we investigated the electrophysiological effects of muscarinic agonists on the 
227 IK-ATP current. We found that (i) under normal conditions acetylcholine did not influence the 
228 action potential duration. (ii) In contrast, when IK-ATP was pharmacologically activated by 
229 pinacidil, subsequently applied acetylcholine lengthened the action potential duration as well 
230 as (iii) reduced the pinacidil-induced ventricle-Purkinje APD dispersion. (iv) In line with this, 
231 carbachol inhibited the IK-ATP that was previously activated by pinacidil. (v) Acetylcholine 
232 increased the APD after hypoxia-induced action potential shortening. 
233
234 Acetylcholine inhibits the IK-ATP in canine ventricular myocytes
235 It is well known that acetylcholine shortens the atrial APD and has been implicated in atrial 
236 fibrillation (Nakayama et al, 1968). Acetylcholine directly affects the GIRK1/4 or 
237 Kir3.1/Kir3.4 channels (Nobles et al, 2018; Corey and Clapham, 1998), encoded by KCNJ3 
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238 and KCNJ4 genes (Kurachi, 1995). These channels are largely expressed in atrial, SA and AV 
239 nodal cells (Galindo et al, 2016; Navarro-Polanco et al, 2013). At the same time, previous 
240 studies (Terzic et al, 1994; Ito et al., 1994) claimed that acetylcholine activates the IK-ATP 
241 channels, even though the physiological consequences of this effect on the action potential 
242 were not clarified.
243
244 The IK-ATP ATP-sensitive potassium channels comprise hetero-octamers consisting of four 
245 inward rectifying potassium channel pore-forming subunits (Kir6.1 or Kir6.2, encoded by 
246 KCNJ8 and KCNJ11 genes, respectively) and four ATP-binding cassette protein 
247 sulphonylurea receptors (SUR1 or SUR2, encoded by ABCC8 and ABCC9 genes, 
248 respectively; Inagaki et al, 195). An important feature of the IK-ATP is its closed state under 
249 physiological intracellular ATP levels (i. e., under normoxia) and its activation by metabolic 
250 stress, when the ratio of ATP/ADP is decreased, e. g., during myocardial ischemia (Deutsch et 
251 al., 1991). 
252
253 Activation of the sarcolemmal IK-ATP during myocardial ischemia shortens the action potential 
254 of various cardiac tissues to different extents, thus it may promote APD dispersion and re-
255 entry type arrhythmias (Janse and Wit, 1989). Accordingly, several investigations found IK-
256 ATP activation to be pro-arrhythmic (Chi et al., 1990), suggesting that sarcolemmal IK-ATP 
257 inhibition may prevent arrhythmias induced by myocardial ischemia and ischemia/reperfusion 
258 (Billman et al, 1998; Englert et al, 2003; Vajda et al, 2007).
259
260 In our experiments under normal conditions, we found no effect of carbachol on the 
261 membrane current (Figure 3) and, similarly, acetylcholine failed to influence the ventricular 
262 and Purkinje APDs (Figures 1A and 1C). The observed discrepancy between our and previous 
263 results, where an activation of IK-ATP was described upon acetylcholine administration (Terzic 
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264 et al, 1994; Ito et al, 1994; Kim et al., 1997), could be the consequence of the species 
265 difference and the distinct experimental conditions. 
266
267 In contrast, an important, and, to the best of our knowledge, previously not published result of 
268 our study is that carbachol is able to suppress the pinacidil-activated IK-ATP. As a consequence, 
269 in parallel tissue action potential experiments, acetylcholine lengthened the APD as long as it 
270 was previously shortened by the application of IK-ATP-activator pinacidil. Since IK-ATP 
271 activation could be arrhythmogenic (Chi et al., 1990) by causing an increase in the APD 
272 dispersion, this effect of acetylcholine raises the possibility of a novel antiarrhythmic 
273 mechanism of the previously described antiarrhythmic effect of parasympathetic activation 
274 during hypoxia (Song et al., 1992; Zuanetti et al., 1987; Collins and Billman, 1989). 
275
276 Our experiments conducted under hypoxic conditions provided similar results (i. e., 
277 acetylcholine lengthened the hypoxia-induced shortened ventricular action potential; 
278 Figure 4). Even though tissue hypoxia is a complex phenomenon (Carmeliet, 1999), during 
279 which several factors change simultaneously (e. g., Ca2+i, Na+i, pH, conductance of gap 
280 junctions, membrane potential etc.), it is feasible that IK-ATP activation, as a response to ATP 
281 depletion, is an important factor in the observed action potential shortening. Since 
282 acetylcholine lengthened the action potential under hypoxic conditions, we suggest IK-ATP 
283 inhibition as a possible underlying mechanism. 
284
285 Acetylcholine decreased the pinacidil-induced ventricle–Purkinje APD dispersion
286 Free-running Purkinje fibers connect to the ventricular muscle on a small surface area, 
287 providing a relatively large-resistance coupling (Tranum-Jensen et al., 1991), and a large sink 
288 for current flow that favors conduction blocks more than other parts of the healthy 
289 myocardium. Also, due to the weaker electrotonic coupling, the dispersion of repolarization 
290 here can be greater than in other areas (Martinez et al., 2018), causing the Purkinje–ventricle 
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291 APD ratio to have critical importance in arrhythmia generation. In our experiments, we found 
292 significantly greater shortening in Purkinje fibers caused by pinacidil that could be the 
293 consequence of the generally weaker repolarization reserve that makes the Purkinje action 
294 potential to be more susceptible to any pharmacological interventions (Varró et al, 2000; 
295 Baláti et al, 1998). Similarly, acetylcholine exerted larger lengthening in the Purkinje fiber 
296 probably by the same reason that ultimately led to reduced ventricle–Purkinje APD 
297 dispersion. The reduction of the ventricle–Purkinje fiber APD dispersion could suppress the 
298 arrhythmogenic substrate providing a narrower vulnerable period for a critically timed 
299 extrasystole to trigger a life-threatening arrhythmia under hypoxic conditions.
300
301 Proposed mechanism
302 Since inhibition of the K-ATP channels is possible by blocking various PKA-mediated 
303 pathways (Tinker et al, 2018.), we suggest that the decrease of cAMP levels caused by the 
304 activation of cardiac muscarinic receptors using acetylcholine/carbachol was the factor that 
305 decreased the density of the IK-ATP current in patch clamp measurements, leading to the 
306 subsequent prolongation observed in action potential durations.
307
308 Conclusions
309 We found that muscarinic agonists inhibit the IK-ATP. Therefore, during IK-ATP-mediated action 
310 potential shortening, acetylcholine causes asymmetrical action potential lengthening between 
311 ventricular muscle and Purkinje fiber that leads to reduced APD dispersion. 
312
313 These results suggest that the parasympathetic tone beyond suppressing the catecholaminerg-
314 induced arrhythmogenic triggers (Song et al., 1992) may be also able to reduce the 
315 arrhythmogenic substrate under hypoxic conditions. 
316
317
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318 Study Limitations
319 (i) In our experiments, the ventricular and Purkinje fiber action potentials were measured 
320 from electrically uncoupled tissue samples. 
321 (ii) The presented effects were attributed to the M2 muscarinic receptor; nevertheless, the 
322 exact level of contribution of other receptor subtypes was not addressed. To achieve this, 
323 further studies are needed, utilizing specific agonist and antagonist drugs.
324
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455 Figure Legends
456 Figure 1. Representative traces of Purkinje fiber (A, B) and ventricular muscle preparations 
457 (C, D); 5 μM acetylcholine (red dotted lines) alone caused no changes in either preparation 
458 type (A, C), while it caused significant prolongation when applied cummulatively after 5 μM 
459 pinacidil (B, D, pinacidil effect represented as blue dashed lines). Bars in panel E represent 
460 the values of APD90 in each treatment group, from top to bottom corresponding to the traces 
461 A to D. Abbreviations under bars: C, control; P, pinacidil, A, acetylcholine. The pacing cycle 
462 length was 500 ms. Values are mean ± SEM; *,# p<0.05 RM-ANOVA followed by 
463 Bonferroni’s post-hoc test.
464
465 Figure 2. Pinacidil (5 μM) increased the action potential duration dispersion (indicated by 
466 ΔAPD90 in percentages, and in ms above the bars) between Purkinje fiber and ventricular 
467 muscle preparations, while acetylcholine (5 μM), when applied after pinacidil, decreased 
468 dispersion. The pacing cycle length was 500 ms.
469
470 Figure 3. Effect of carbachol on IK-ATP. Ionic currents were measured under a slow voltage 
471 ramp protocol (panel A) between -120 mV and 60 mV. The currents were analysed at 0 and 
472 30 mV. Panel B demonstrates original representative current traces (left) and bar graphs 
473 (right) where 3 μM carbachol (dotted line) failed to influence the control current analysed at 
474 0 mV. Inset shows identical current fractions between –3 mV and 45 mV (indicated by dashed 
475 rectangle). Current traces in panel C as well as in the inset, illustrate large increase of the 
476 membrane current after application of 5 μM pinacidil (blue dashed line) that was inhibited by 
477 the subsequently applied 3 μM carbachol (red dotted line). In bar graphs (right), asterisk 
478 denotes significant change between control (left column) and pinacidil (middle column), 
479 while hash tag indicates significant change between pinacidil (middle column) and carbachol 
480 (right column). 
481
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482 Figure 4. Representative action potential trace (A) showing that hypoxic conditions caused 
483 significant action potential duration abbreviation and decreased mean diastolic potential and 
484 amplitude in canine ventricular preparations (blue dashed line), while acetylcholine (5 μM) 
485 caused a significant prolongation in action potential duration (red dotted line). Values of 
486 APD90 are represented as bars (B). Abbreviations under bars: C, control; H, hypoxia, A, 
487 acetylcholine. The pacing cycle length was 500 ms. Values are mean ± SEM; *,#p<0.05, 
488 RM-ANOVA followed by Bonferroni’s post-hoc test.
489
490 Figure 5. Representative action potential showing the effect of acetylcholine (5 μM, red 
491 dotted line) on a Purkinje fiber taken from a human donor heart (A). Values of APD90 are 
492 represented as bars (B). Abbreviations under bars: C, control; A, acetylcholine. The pacing 
493 cycle length was 500 ms. Values are mean ± SEM.
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28 Abstract
29 Introduction: Activation of the parasympathetic nervous system has been reported to have an 
30 antiarrhythmic role during ischemia-reperfusion injury by decreasing the arrhythmia triggers. 
31 Furthermore, it was reported that the parasympathetic neurotransmitter acetylcholine is able to 
32 modulate the ATP-dependent K-current (IK-ATP), a crucial current activated during hypoxia. 
33 However, the possible significance of this current modulation in the antiarrhythmic 
34 mechanism is not fully clarified. 
35 Methods: Action potentials were measured using the conventional microelectrode technique 
36 from canine left ventricular papillary muscle and free-running Purkinje fibers, under normal 
37 and hypoxic conditions. Ionic currents were measured using the whole-cell configuration of 
38 the patch clamp method.
39 Results: 5 μM acetylcholine did not influence the action potential duration (APD) either in 
40 Purkinje fibers or in papillary muscle preparations. In contrast, it significantly lengthened the 
41 APD and suppressed the Purkinje–ventricle APD dispersion when it was administered after 
42 5 μM pinacidil application. 3 μM carbachol reduced the pinacidil-activated IK-ATP under 
43 voltage-clamp condition. Acetylcholine lengthened the ventricular action potential under 
44 simulated ischemia condition.
45 Conclusion: In this study we found that acetylcholine inhibits the IK-ATP and thus suppresses 
46 the ventricle-Purkinje APD dispersion. We conclude that parasympathetic tone may reduce 
47 the arrhythmogenic substrate exerting a complex antiarrhythmic mechanism during hypoxic 
48 conditions. 
49
50 Key words: acetylcholine, Purkinje fibers, papillary muscles, hypoxia
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51 Introduction
52 The parasympathetic nervous system has a crucial role in controlling the actual heart rate and 
53 impulse propagation via influencing the sinoatrial and atrioventricular nodes (Higgins et al., 
54 1973). The parasympathetic nerve endings operate by releasing acetylcholine that acts on 
55 M2-receptors, activating several intracellular signaling routes, and ultimately influencing the 
56 cardiac ion channels (Harvey and Belevych, 2003). Even though the parasympathetic nervous 
57 system primarily innervates the supraventricular areas of the heart, there are certain important 
58 ion channels in the ventricular muscle that are known to be influenced by the release of 
59 acetylcholine. It has been previously reported that the inward rectifier potassium current (IK1; 
60 Koumi et al., 1995) and the slow component of the delayed rectifier (IKs; Pappano and 
61 Carmeliet, 1979) are inhibited, whereas IK-ATP and IK-ACh are activated by acetylcholine via 
62 G proteins (Terzic et al, 1994; Ito et al., 1994; Kim et al., 1997).
63
64 The importance of these effects of acetylcholine is underpinned by the fact that the activation 
65 of IK-ATP channels is well known during hypoxia/ischemia, in which situations the duration of 
66 the action potential is shortened (Weiss and Venkatesh, 1993). Furthermore, it was reported 
67 that vagal activation is also facilitated under ischemia–reperfusion (Recordati et al., 1971). 
68 This vagal activation during hypoxia could be antiarrhythmic, since it was reported that 
69 increased parasympathetic tone reduces the catecholaminerg-induced early and delayed 
70 afterdepolarizations (arrhythmia triggers) (Song et al., 1992), as well as the incidence of 
71 ventricular fibrillation (Zuanetti et al., 1987; Collins and Billman, 1989). However, the 
72 underlying mechanism of antiarrhythmic effect of M2-receptor activation is not fully clarified. 
73 Arrhythmias may develop when an arrhythmogenic substrate (e. g., dispersion of 
74 repolarization) and arrhythmia triggers (e.g.: early and delayed afterdepolarizations) 
75 simultaneously exist in the heart. The arrhythmogenic substrate could be prominent at 
76 Purkinje–ventricle connection because of the relatively weak electrotonic coupling due to low 
77 number of gap junctions (Varró and Baczkó, 2010). As a consequence of the different 
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78 pharmacological susceptibility of Purkinje fiber and ventricular muscle (Baláti et al, 1998), 
79 the activation of IK-ATP may modulate the Purkinje and ventricular action potential duration 
80 (APD) to different extents, and the developed APD dispersion may contribute to the onset of 
81 arrhythmias.
82
83 The objective of this study was the investigation of the possible effect of acetylcholine on the 
84 IK-ATP and on the IK-ATP-mediated action potential dispersion under normal and hypoxic 
85 conditions. 
86
87 Methods
88 Human tissues
89 Non-diseased human hearts that were unusable for transplantation (based on logistical, not 
90 patient-related considerations) were obtained from organ donors. Before cardiac explanation, 
91 organ donor patients did not receive medication except dobutamine, furosemide and plasma 
92 expanders. The investigations conform to the principles outlined in the Declaration of 
93 Helsinki of the World Medical Association. All experimental protocols were approved by the 
94 Scientific and Research Ethical Committee of the Medical Scientific Board at the Hungarian 
95 Ministry of Health (ETT-TUKEB), under ethical approval No 4991-0/2010-1018EKU 
96 (339/PI/010). Human cardiac tissue was stored in cardioplegic solution at 4°C for 4–8 hours.
97
98 Animals
99 All experiments using canine cardiac preparations were carried out in compliance with the 
100 Guide for the Care and Use of Laboratory Animals (USA NIH publication NO 85-23, revised 
101 1996) and conformed to the Directive 2010/63/EU of the European Parliament. The protocols 
102 have been approved by the Ethical Committee for the Protection of Animals in Research of 
103 the University of Szeged, Szeged, Hungary (approval number: I-74-24-2017) and by the 
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104 Department of Animal Health and Food Control of the Ministry of Agriculture and Rural 
105 Development (authority approval number XIII/3331/2017).
106
107 Conventional microelectrode technique
108 Ventricular (papillary or trabecular) muscles were obtained from the right ventricle of canine 
109 hearts. Free-running Purkinje fibers were identified as false tendons and isolated from both 
110 ventricles of human and canine hearts. Canine hearts were removed through a right lateral 
111 thoracotomy from anesthetized (thiopental 30 mg/kg i.v.) mongrel dogs of either sex 
112 weighing 10–15 kg. At impalement, Purkinje fibers were observed under a surgical 
113 microscope (Zeiss OPMI PRO). The preparations were placed in Locke’s solution and 
114 allowed to equilibrate for at least 2 hours while superfused (flow rate 4-5 ml/min) also with 
115 Locke’s solution containing (in mM): NaCl 120, KCl 4, CaCl2 2, MgCl2 1, NaHCO3 22, and 
116 glucose 11. The pH of this solution was 7.40 to 7.45 when gassed with 95% O2 and 5% CO2 
117 at 37 °C. In the experiments where the effects of tissue hypoxia were examined, we changed 
118 the gas mixture to 95% N2 and 5% CO2, pH remained at 7.40 to 7.45. All experiments were 
119 performed at 37 °C. During the equilibration period, preparations were stimulated at a basic 
120 cycle length of 500 ms. Electrical pulses of 0.5–2 ms in duration at twice the diastolic 
121 threshold in intensity (S1) were delivered to the preparations through bipolar platinum 
122 electrodes. Transmembrane potentials were recorded using glass capillary microelectrodes 
123 filled with 3 M KCl (tip resistance: 5 to 15 MΩ). The microelectrodes were coupled through 
124 an Ag-AgCl junction to the input of a high-impedance, capacitance-neutralizing amplifier 
125 (Experimetria 2011). Intracellular recordings were displayed on a storage oscilloscope 
126 (Hitachi V-555) and led to a computer system (APES) designed for on-line determination of 
127 the following parameters: resting membrane potential, action potential amplitude, action 
128 potential duration at 10% to 90% repolarization and the maximum rate of rise of the action 
129 potential upstroke (Vmax). Control recordings were obtained after equilibration period. The 
130 compounds used in all experiments were purchased from Sigma/Merck.
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131 2.3. Cell isolation
132 Ventricular myocytes were enzymatically dissociated from the left ventricle of dog hearts. 
133 Canine hearts were removed through a right lateral thoracotomy from anesthetized (thiopental 
134 30 mg/kg i.v.) mongrel dogs of either sex weighing 10–15 kg. Cardiac myocytes were isolated 
135 from the left ventricle, containing an arterial branch through which the segment was perfused 
136 on a Langendorff apparatus with solutions in the following sequence: normal Tyrode's 
137 solution (containing in mM: 144 mM NaCl, 0.4 mM NaH2PO4, 4 mM KCl, 0.53 mM MgSO4, 
138 1.8 mM CaCl2, 5.5 mM Glucose, 5 mM HEPES, pH 7.4 adjusted with NaOH) for 10 min, 
139 Ca2+-free Tyrode solution for 10 min and Ca2+-free Tyrode solution containing collagenase 
140 (Worthington type II, 0.66 mg/mL). To the final perfusion solution protease (type XIV, 0.12 
141 mg/mL) was added at the 15 and the 30 minutes for digestion.
142
143 2.4. Measurement of ionic currents
144 One drop of cell suspension was placed in a transparent recording chamber mounted on the 
145 stage of an inverted microscope (Olympus IX51, Tokyo, Japan), and individual myocytes 
146 were allowed to settle and adhere to the chamber bottom for at least 5–10 min before 
147 superfusion was initiated and maintained by gravity. Only rod-shaped cells with clear 
148 striations were used. HEPES-buffered Tyrode’s solution (composition in mM: NaCl 144, 
149 NaH2PO4 0.4, KCl 4.0, CaCl2 1.8, MgSO4 0.53, glucose 5.5 and HEPES 5.0, at pH of 7.4) 
150 was used as the normal superfusate. During the measurement of IK-ATP, 1 µM nisoldipine was 
151 added to the bath solution to block ICaL, IKr was blocked by 0.1 µM dofetilide, and IKs was 
152 blocked by 0.5 µM HMR-1556. Micropipettes were fabricated from borosilicate glass 
153 capillaries (Science Products GmbH, Hofheim, Germany), using a P-97 Flaming/Brown 
154 micropipette puller (Sutter Co, Novato, CA, USA), and had a resistance of 1.5–2.5 MΩ when 
155 filled with pipette solution. The membrane currents were recorded with Axopatch-200B 
156 amplifiers (Molecular Devices, Sunnyvale, CA, USA) by applying the whole-cell 
157 configuration of the patch-clamp technique. The membrane currents were digitized with 250 
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158 kHz analogue to digital converters (Digidata 1440A, Molecular Devices, Sunnyvale, CA, 
159 USA) under software control (pClamp 8 and pClamp 10, Molecular Devices, Sunnyvale, CA, 
160 USA).  The composition of the pipette solution (in mM) was the following: KOH 110, KCl 
161 40, K2ATP 5, MgCl2 5, EGTA 5, HEPES 10 and GTP 0.1 (pH was adjusted to 7.2 by aspartic 
162 acid). 
163
164 2.5 Statistical analysis
165 Results are expressed as mean ± S.E.M. Normality of distributions was verified using 
166 Shapiro-Wilk test, and homogeneity of variances was verified using Bartlett's test in each 
167 treatment group. Statistical comparisons were made using analysis of variance (ANOVA) for 
168 repeated measurements, followed by Bonferroni’s post-hoc test. Differences were considered 
169 significant when p < 0.05.
170
171 Results
172 1. Acetylcholine lengthened the APD after pinacidil-mediated action potential shortening
173 Canine Purkinje fibers and ventricular papillary muscles were paced at 500 ms cycle length. 
174 In canine Purkinje fibers (PFs; n=15), acetylcholine (5 µM) did not affect the repolarization 
175 (233.6±4.7 to 231.7±4.6; Figures 1A and 1E). In contrast, in canine Purkinje fibers (n=8), the 
176 IK-ATP activator pinacidil, applied in 5 μM concentration, significantly abbreviated APD90 
177 (207.7±7.0 ms vs 113.1±9.1 ms, p<0.05) values. After steady state was reached, acetylcholine 
178 was administered. Within 3 minutes, acetylcholine prolonged APD90 to 147.3±7.4 ms, 
179 partially reversing the effects of pinacidil (Figures 1B and 1E; p<0.05).
180
181 Similarly, as observed in Purkinje fibers, 5 μM acetylcholine alone failed to influence the 
182 APD of the ventricular muscle (APD90: 172.6±5.7 ms vs 172.8±5.3 ms). Pinacidil (n=5; 
183 5 μM) pretreatment significantly abbreviated the APD90 value (187.9±4.5 ms vs 
184 163.7±6.4 ms, p<0.05), similarly to the effects observed in the case of PFs. After a period of 
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185 30 minutes, sufficient to reach a steady state, acetylcholine was added to the superfusate. 
186 Within 4 minutes, acetylcholine (5 μM) prolonged APD90 to 172.1±7.4 ms (p<0.05), thus 
187 partially reversing the effects of pinacidil (Figures 1D and 1E). 
188
189 2. Acetylcholine decreased the calculated APD dispersion between PF and VM
190 The changes in the difference between the APD90 values of PF and VM can be used to infer 
191 the effects of pinacidil and acetylcholine on the dispersion between these cardiac tissue types 
192 (Figure 2). The control APD90 dispersion (9.5%, 20 ms) was significantly increased upon 
193 5 μM pinacidil application (44.7%, 51 ms). On the other hand, subsequently applied 5 μM 
194 acetylcholine markedly decreased the repolarization heterogeneity (16.9%, 28 ms; p<0.05). 
195
196 3. Carbachol decreased the pinacidil-induced current activation
197 During ionic current measurements, voltage ramps were used from a holding potential of 
198 -90 mV. Membrane potential was hyperpolarized to -120 mV, and then was slowly (over 36 s) 
199 depolarized to 60 mV. Ionic currents were analyzed and compared at 0 and +30 mV. We 
200 found that carbachol did not change the control current when it was applied without pinacidil 
201 (0 mV - control: 0.20±0.2 pA/pF vs 3 μM carbachol: 0.32±0.2 pA/pF, n=6 and +30 mV - 
202 control: 0.55±0.4 pA/pF vs 3 μM carbachol: 0.74±0.3 pA/pF, n=6). In contrast, when 5 μM 
203 pinacidil was applied first, subsequently employed carbachol significantly reduced the current 
204 at both voltages (0 mV – control: 0.24±0.2 pA/pF  5 μM pinacidil: 2.03±0.3 pA/pF  3 
205 μM carbachol: 1.51±0.4 pA/pF, n=8, p<0.05. +30 mV - control: 0.78±0.6 pA/pF  5 μM 
206 pinacidil: 3.17±0.3 pA/pF  3 μM carbachol: 2.26±0.3 pA/pF, n=8, p<0.05). 
207
208 These measurements were carried out with acetylcholine as well. However, we found 
209 carbachol to be more stable during the applied long voltage protocol. 
210
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211 4. Acetylcholine restored the APD after hypoxia-induced action potential shortening
212 Simulated hypoxia, achieved by gassing the solution with N2 and CO2 instead of O2 and CO2, 
213 resulted in a significant abbreviation of APD90 from 181.4±5.7 ms to 135.0±8.6 ms (p<0.05, 
214 Figures 4A and 4B), and a decrease in amplitude (103.7±2.8 mV vs 92±3.5 mV). The 
215 maximum rate of depolarization was also decreased (185.8±15.8 V/s vs 156.1±20.6 V/s). 
216 When applied during hypoxia, 5 μM acetylcholine caused a significant APD90 prolongation to 
217 164.4±4.4 ms, partially reversing the effect of hypoxia on the repolarization. AMP returned to 
218 a normal range (102.1±1.6 mV), while Vmax remained at 156.0±16.1 V/s.
219
220 5. Acetylcholine caused a slight abbreviation in human Purkinje fibers
221 In human PFs (n=2), acetylcholine in 5 μM concentration caused a slight abbreviation of 
222 APD90 from 269.0±28.4 to 251.6±42.85 ms and APD50 from 184.4±20.0 ms to 
223 173.3±27.1 ms without affecting other characteristics of the action potential (Figure 5).
224
225 Discussion
226 In this study we investigated the electrophysiological effects of muscarinic agonists on the 
227 IK-ATP current. We found that (i) under normal conditions acetylcholine did not influence the 
228 action potential duration. (ii) In contrast, when IK-ATP was pharmacologically activated by 
229 pinacidil, subsequently applied acetylcholine lengthened the action potential duration as well 
230 as (iii) reduced the pinacidil-induced ventricle-Purkinje APD dispersion. (iv) In line with this, 
231 carbachol inhibited the IK-ATP that was previously activated by pinacidil. (v) Acetylcholine 
232 increased the APD after hypoxia-induced action potential shortening. 
233
234 Acetylcholine inhibits the IK-ATP in canine ventricular myocytes
235 It is well known that acetylcholine shortens the atrial APD and has been implicated in atrial 
236 fibrillation (Nakayama et al, 1968). Acetylcholine directly affects the GIRK1/4 or 
237 Kir3.1/Kir3.4 channels (Nobles et al, 2018; Corey and Clapham, 1998), encoded by KCNJ3 
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238 and KCNJ4 genes (Kurachi, 1995). These channels are largely expressed in atrial, SA and AV 
239 nodal cells (Galindo et al, 2016; Navarro-Polanco et al, 2013). At the same time, previous 
240 studies (Terzic et al, 1994; Ito et al., 1994) claimed that acetylcholine activates the IK-ATP 
241 channels, even though the physiological consequences of this effect on the action potential 
242 were not clarified.
243
244 The IK-ATP ATP-sensitive potassium channels comprise hetero-octamers consisting of four 
245 inward rectifying potassium channel pore-forming subunits (Kir6.1 or Kir6.2, encoded by 
246 KCNJ8 and KCNJ11 genes, respectively) and four ATP-binding cassette protein 
247 sulphonylurea receptors (SUR1 or SUR2, encoded by ABCC8 and ABCC9 genes, 
248 respectively; Inagaki et al, 195). An important feature of the IK-ATP is its closed state under 
249 physiological intracellular ATP levels (i. e., under normoxia) and its activation by metabolic 
250 stress, when the ratio of ATP/ADP is decreased, e. g., during myocardial ischemia (Deutsch et 
251 al., 1991). 
252
253 Activation of the sarcolemmal IK-ATP during myocardial ischemia shortens the action potential 
254 of various cardiac tissues to different extents, thus it may promote APD dispersion and re-
255 entry type arrhythmias (Janse and Wit, 1989). Accordingly, several investigations found IK-
256 ATP activation to be pro-arrhythmic (Chi et al., 1990), suggesting that sarcolemmal IK-ATP 
257 inhibition may prevent arrhythmias induced by myocardial ischemia and ischemia/reperfusion 
258 (Billman et al, 1998; Englert et al, 2003; Vajda et al, 2007).
259
260 In our experiments under normal conditions, we found no effect of carbachol on the 
261 membrane current (Figure 3) and, similarly, acetylcholine failed to influence the ventricular 
262 and Purkinje APDs (Figures 1A and 1C). The observed discrepancy between our and previous 
263 results, where an activation of IK-ATP was described upon acetylcholine administration (Terzic 
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264 et al, 1994; Ito et al, 1994; Kim et al., 1997), could be the consequence of the species 
265 difference and the distinct experimental conditions. 
266
267 In contrast, an important, and, to the best of our knowledge, previously not published result of 
268 our study is that carbachol is able to suppress the pinacidil-activated IK-ATP. As a consequence, 
269 in parallel tissue action potential experiments, acetylcholine lengthened the APD as long as it 
270 was previously shortened by the application of IK-ATP-activator pinacidil. Since IK-ATP 
271 activation could be arrhythmogenic (Chi et al., 1990) by causing an increase in the APD 
272 dispersion, this effect of acetylcholine raises the possibility of a novel antiarrhythmic 
273 mechanism of the previously described antiarrhythmic effect of parasympathetic activation 
274 during hypoxia (Song et al., 1992; Zuanetti et al., 1987; Collins and Billman, 1989). 
275
276 Our experiments conducted under hypoxic conditions provided similar results (i. e., 
277 acetylcholine lengthened the hypoxia-induced shortened ventricular action potential; 
278 Figure 4). Even though tissue hypoxia is a complex phenomenon (Carmeliet, 1999), during 
279 which several factors change simultaneously (e. g., Ca2+i, Na+i, pH, conductance of gap 
280 junctions, membrane potential etc.), it is feasible that IK-ATP activation, as a response to ATP 
281 depletion, is an important factor in the observed action potential shortening. Since 
282 acetylcholine lengthened the action potential under hypoxic conditions, we suggest IK-ATP 
283 inhibition as a possible underlying mechanism. 
284
285 Acetylcholine decreased the pinacidil-induced ventricle–Purkinje APD dispersion
286 Free-running Purkinje fibers connect to the ventricular muscle on a small surface area, 
287 providing a relatively large-resistance coupling (Tranum-Jensen et al., 1991), and a large sink 
288 for current flow that favors conduction blocks more than other parts of the healthy 
289 myocardium. Also, due to the weaker electrotonic coupling, the dispersion of repolarization 
290 here can be greater than in other areas (Martinez et al., 2018), causing the Purkinje–ventricle 
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291 APD ratio to have critical importance in arrhythmia generation. In our experiments, we found 
292 significantly greater shortening in Purkinje fibers caused by pinacidil that could be the 
293 consequence of the generally weaker repolarization reserve that makes the Purkinje action 
294 potential to be more susceptible to any pharmacological interventions (Varró et al, 2000; 
295 Baláti et al, 1998). Similarly, acetylcholine exerted larger lengthening in the Purkinje fiber 
296 probably by the same reason that ultimately led to reduced ventricle–Purkinje APD 
297 dispersion. The reduction of the ventricle–Purkinje fiber APD dispersion could suppress the 
298 arrhythmogenic substrate providing a narrower vulnerable period for a critically timed 
299 extrasystole to trigger a life-threatening arrhythmia under hypoxic conditions.
300
301 Proposed mechanism
302 Since inhibition of the K-ATP channels is possible by blocking various PKA-mediated 
303 pathways (Tinker et al, 2018.), we suggest that the decrease of cAMP levels caused by the 
304 activation of cardiac muscarinic receptors using acetylcholine/carbachol was the factor that 
305 decreased the density of the IK-ATP current in patch clamp measurements, leading to the 
306 subsequent prolongation observed in action potential durations.
307
308 Conclusions
309 We found that muscarinic agonists inhibit the IK-ATP. Therefore, during IK-ATP-mediated action 
310 potential shortening, acetylcholine causes asymmetrical action potential lengthening between 
311 ventricular muscle and Purkinje fiber that leads to reduced APD dispersion. 
312
313 These results suggest that the parasympathetic tone beyond suppressing the catecholaminerg-
314 induced arrhythmogenic triggers (Song et al., 1992) may be also able to reduce the 
315 arrhythmogenic substrate under hypoxic conditions. 
316
317
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318 Study Limitations
319 (i) In our experiments, the ventricular and Purkinje fiber action potentials were measured 
320 from electrically uncoupled tissue samples. 
321 (ii) The presented effects were attributed to the M2 muscarinic receptor; nevertheless, the 
322 exact level of contribution of other receptor subtypes was not addressed. To achieve this, 
323 further studies are needed, utilizing specific agonist and antagonist drugs.
324
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455 Figure Legends
456 Figure 1. Representative traces of Purkinje fiber (A, B) and ventricular muscle preparations 
457 (C, D); 5 μM acetylcholine (red dotted lines) alone caused no changes in either preparation 
458 type (A, C), while it caused significant prolongation when applied cummulatively after 5 μM 
459 pinacidil (B, D, pinacidil effect represented as blue dashed lines). Bars in panel E represent 
460 the values of APD90 in each treatment group, from top to bottom corresponding to the traces 
461 A to D. Abbreviations under bars: C, control; P, pinacidil, A, acetylcholine. The pacing cycle 
462 length was 500 ms. Values are mean ± SEM; *,# p<0.05 RM-ANOVA followed by 
463 Bonferroni’s post-hoc test.
464
465 Figure 2. Pinacidil (5 μM) increased the action potential duration dispersion (indicated by 
466 ΔAPD90 in percentages, and in ms above the bars) between Purkinje fiber and ventricular 
467 muscle preparations, while acetylcholine (5 μM), when applied after pinacidil, decreased 
468 dispersion. The pacing cycle length was 500 ms.
469
470 Figure 3. Effect of carbachol on IK-ATP. Ionic currents were measured under a slow voltage 
471 ramp protocol (panel A) between -120 mV and 60 mV. The currents were analysed at 0 and 
472 30 mV. Panel B demonstrates original representative current traces (left) and bar graphs 
473 (right) where 3 μM carbachol (dotted line) failed to influence the control current analysed at 
474 0 mV. Inset shows identical current fractions between –3 mV and 45 mV (indicated by dashed 
475 rectangle). Current traces in panel C as well as in the inset, illustrate large increase of the 
476 membrane current after application of 5 μM pinacidil (blue dashed line) that was inhibited by 
477 the subsequently applied 3 μM carbachol (red dotted line). In bar graphs (right), asterisk 
478 denotes significant change between control (left column) and pinacidil (middle column), 
479 while hash tag indicates significant change between pinacidil (middle column) and carbachol 
480 (right column). 
481
Page 38 of 52
© The Author(s) or their Institution(s)
Canadian Journal of Physiology and Pharmacology
Draft
482 Figure 4. Representative action potential trace (A) showing that hypoxic conditions caused 
483 significant action potential duration abbreviation and decreased mean diastolic potential and 
484 amplitude in canine ventricular preparations (blue dashed line), while acetylcholine (5 μM) 
485 caused a significant prolongation in action potential duration (red dotted line). Values of 
486 APD90 are represented as bars (B). Abbreviations under bars: C, control; H, hypoxia, A, 
487 acetylcholine. The pacing cycle length was 500 ms. Values are mean ± SEM; *,#p<0.05, 
488 RM-ANOVA followed by Bonferroni’s post-hoc test.
489
490 Figure 5. Representative action potential showing the effect of acetylcholine (5 μM, red 
491 dotted line) on a Purkinje fiber taken from a human donor heart (A). Values of APD90 are 
492 represented as bars (B). Abbreviations under bars: C, control; A, acetylcholine. The pacing 
493 cycle length was 500 ms. Values are mean ± SEM.
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Figure 1. Representative traces of Purkinje fiber (A, B) and ventricular muscle preparations (C, D); 5 μM 
acetylcholine (red dotted lines) alone caused no changes in either preparation type (A, C), while it caused 
significant prolongation when applied cummulatively after 5 μM pinacidil (B, D, pinacidil effect represented 
as blue dashed lines). Bars in panel E represent the values of APD90 in each treatment group, from top to 
bottom corresponding to the traces A to D. Abbreviations under bars: C, control; P, pinacidil, A, 
acetylcholine. The pacing cycle length was 500 ms. Values are mean ± SEM; *,# p<0.05 RM-ANOVA 
followed by Bonferroni’s post-hoc test. 
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Figure 2. Pinacidil (5 μM) increased the action potential duration dispersion (indicated by ΔAPD90 in 
percentages, and in ms above the bars) between Purkinje fiber and ventricular muscle preparations, while 
acetylcholine (5 μM), when applied after pinacidil, decreased dispersion. The pacing cycle length was 500 
ms. 
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Figure 3. Effect of carbachol on IK-ATP. Ionic currents were measured under a slow voltage ramp protocol 
(panel A) between -120 mV and 60 mV. The currents were analysed at 0 and 30 mV. Panel B demonstrates 
original representative current traces (left) and bar graphs (right) where 3 μM carbachol (dotted line) failed 
to influence the control current analysed at 0 mV. Inset shows identical current fractions between –3 mV 
and 45 mV (indicated by dashed rectangle). Current traces in panel C as well as in the inset, illustrate large 
increase of the membrane current after application of 5 μM pinacidil (blue dashed line) that was inhibited by 
the subsequently applied 3 μM carbachol (red dotted line). In bar graphs (right), asterisk denotes significant 
change between control (left column) and pinacidil (middle column), while hash tag indicates significant 
change between pinacidil (middle column) and carbachol (right column). 
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Figure 4. Representative action potential trace (A) showing that hypoxic conditions caused significant action 
potential duration abbreviation and decreased mean diastolic potential and amplitude in canine ventricular 
preparations (blue dashed line), while acetylcholine (5 μM) caused a significant prolongation in action 
potential duration (red dotted line). Values of APD90 are represented as bars (B). Abbreviations under bars: 
C, control; H, hypoxia, A, acetylcholine. The pacing cycle length was 500 ms. Values are mean ± SEM; 
*,#p<0.05, RM-ANOVA followed by Bonferroni’s post-hoc test. 
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Figure 5. Representative action potential showing the effect of acetylcholine (5 μM, red dotted line) on a 
Purkinje fiber taken from a human donor heart (A). Values of APD90 are represented as bars (B). 
Abbreviations under bars: C, control; A, acetylcholine. The pacing cycle length was 500 ms. Values are 
me n ± SEM. 
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12 Introduction
13 Acetylcholine has been previously shown to augment J-point elevation and to induce phase-2 reentry, 
14 thus precipitating polymorphic ventricular tachycardia in preparations pretreated with agents designed 
15 to pharmacologically mimic the genetic defects previously shown to be associated with the early 
16 repolarization syndrome (ERS). Previously, Haïssaguerre et al. (2008) have described that extrasystolic 
17 activity arising from the Purkinje network is able to precipitate ventricular tachyarrhythmias in the 
18 setting of ERS. We examined Purkinje fibers under conditions pharmacologically mimicking the ion 
19 channel changes caused by the genetic defects previously reported to be associated with ERS, including 
20 gain of function in IK-ATP (KCNJ8 and ABCC9) or Ito (SCN1Bb and KCND3) (Hu et al., 2014b; Barajas-
21 Martínez et al., 2014; Haïssaguerre et al., 2009) or loss of function in ICa (CACNA1C, CACNB2 and 
22 CACNA2D1) (Burashnikov et al., 2010; Napolitano and Antzelevitch, 2011) or INa (SCN5A and 
23 SCN10A) (Watanabe et al., 2011; Hu et al., 2014a), and applied an antiarrhytmic drug successfully used 
24 to treat ventricular tachyarrhythmias in ERS: cilostazol (Iguchi et al., 2013; Shinohara et al., 2014; ).
25
26 Methods
27 Conventional microelectrode technique
28 All experiments were performed on canine Purkinje fibers using the conventional microelectrode 
29 technique. The preparations were placed in Locke’s solution and allowed to equilibrate for at least 2 
30 hours while superfused (flow rate 4-5 ml/min) also with Locke’s solution containing (in mM): NaCl 
31 120, KCl 4, CaCl2 2, MgCl2 1, NaHCO3 22, and glucose 11. The pH of this solution was 7.40 to 7.45 
32 when gassed with 95% O2 and 5% CO2 at 37 °C. All experiments were performed at 37 °C. Electrical 
33 pulses of 0.5–2 ms in duration at twice the diastolic threshold in intensity (S1) were delivered to the 
34 preparations through bipolar platinum electrodes at a basic cycle length of 500 ms. Transmembrane 
35 potentials were recorded using glass capillary microelectrodes filled with 3 M KCl (tip resistance: 5 to 
36 15 MΩ). The microelectrodes were coupled through an Ag-AgCl junction to the input of a 
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37 high-impedance, capacitance-neutralizing amplifier (Experimetria 2011). Intracellular recordings were 
38 displayed on a storage oscilloscope (Hitachi V-555) and led to a computer system.
39
40 Pharmacological models
41 Our pharmacological models of the early repolarization syndrome in Purkinje fibers were based on 
42 previous experiments (Koncz et al., 2014; Gurabi et al., 2014). We pharmacologically mimicked the 
43 ion channel changes caused by the genetic defects associated with ERS: pinacidil (5 μM; IK-ATP gain of 
44 function), NS5806 (7 μM; Ito gain of function), nisoldipine (1 μM; ICa loss of function), mexiletine 
45 (20 μM; INa loss of function). The more efficacious enantiomer of mexiletine, R-mexiletine was used 
46 (Gurabi et al., 2017); the concentration corresponds to a peak therapeutic plasma concentration (Varró 
47 and Lathrop, 1990). The application of each compound was followed by an equilibration period, 
48 enabling the tissue to reach steady-state, then the next compound was administered in a cumulative 
49 manner. Acetylcholine (5 μM) was used to simulate increased parasympathetic tone. Cilostazol 
50 (10 μM) was applied after acetylcholine.
51
52 Results
53 Model 1: Pinacidil + acetylcholine + cilostazol (n=6)
54 The effects of pinacidil and acetylcholine were described in the main article. Cilostazol caused a 
55 notable plateau elevation without changing repolarization (Figure A1-A).
56
57 Model 2: NS5806 + pinacidil + acetylcholine + cilostazol (n=5)
58 Cilostazol significantly increased action potential duration (APD) when applied after NS5806, pinacidil 
59 and acetylcholine (Figure A1-B). 
60
61
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62 Model 3: Mexiletine + NS5806 + cilostazol (n=4)
63 After inhibition of INa by mexiletine, followed by the activation Ito by NS5806 and the administration of 
64 acetylcholine, cilostazol caused a slight prolongation of the APD (Figure A1-C).
65
66 Model 4: Nisoldipine + NS5806 + acetylcholine + cilostazol (n=4)
67 Cilostazol was also applied after nisoldipine, NS5806 and acetylcholine, causing a slight plateau 
68 elevation and slight APD prolongation (Figure A1-D).
69
70 Conclusion
71 Since most conventional antiarrhythmic drugs, including beta-blockers, verapamil, lidocaine or 
72 amiodarone, are not capable of suppressing tachyarrhythmic episodes in the early repolarization 
73 syndrome, cilostazol should remain a prominent candidate in clinical trials related to early 
74 repolarization. Formerly, we found Ito blocking ability of cilostazol (Patocskai et al., 2016) next to its 
75 ability to augment ICa (Matsui et al., 1999). The above detailed normalization of the repolarization 
76 defect might carry a possible therapeutic value of cilostazol in early repolarization (ER), when the 
77 origin of arrhythmic activity is localized to the Purkinje system. 
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149 Appendix figure legend
150 Figure A1. Representative action potential traces from canine Purkinje fibers showing the effects of 
151 10 μM cilostazol (continuous lines) in the following models of the early repolarization syndrome (ERS, 
152 dotted lines): pinacidil 5 μM + acetylcholine 5 μM (Model 1; A), NS5806 7 μM + pinacidil 5 μM + 
153 acetylcholine 5 μM (Model 2; B), mexiletine 20 μM + NS5806 7 μM  (Model 3; C), and nisoldipine 
154 1 μM + NS5806 7 μM + acetylcholine 5 μM (Model 4; D).
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Figure A1. Representative action potential traces from canine Purkinje fibers showing the effects of 10 μM 
cilostazol (continuous lines) in the following models of the early repolarization syndrome (ERS, dotted lines): 
pinacidil 5 μM + acetylcholine 5 μM (Model 1; A), NS5806 7 μM + pinacidil 5 μM + acetylcholine 5 μM 
(Model 2; B), mexiletine 20 μM + NS5806 7 μM  (Model 3; C), and nisoldipine 1 μM + NS5806 7 μM + 
acetylcholine 5 μM (Model 4; D). 
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